Rapid Micro Biosystems (RPID) Cash & Current Investments (2020 - 2026)
Rapid Micro Biosystems (RPID) posted Cash & Current Investments of $9.4 million for Q1 2026, down 48.63% sequentially from $18.4 million in Q4 2025, and down 58.74% YoY from $22.9 million in Q1 2025.
Rapid Micro Biosystems (RPID) Cash & Current Investments (2020 - 2026) Analysis & Trends
Rapid Micro Biosystems has reported Cash & Current Investments for 7 years, with the latest figure at $9.4 million in Q1 2026.
- Quarterly Cash & Current Investments fell 58.74% year-over-year to $9.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $9.4 million (down 58.74% YoY) and the FY2025 annual result came in at $18.4 million, down 63.8% from the prior year.
- Cash & Current Investments declined to $9.4 million in Q1 2026 per RPID's latest filing, from $18.4 million in the prior quarter.
- Over five years, Cash & Current Investments peaked at $162.2 million in Q1 2022 and troughed at $9.4 million in Q1 2026.
- A 5-year average of $67.0 million and a median of $60.8 million in 2024 frame the typical range for Cash & Current Investments.
- The sharpest annual moves came in 2022 and 2025: Cash & Current Investments jumped 430.72% in 2022, then tumbled 63.8% in 2025.
- Over 5 years, Cash & Current Investments stood at $81.8 million in 2022, then decreased by 17.02% to $67.9 million in 2023, then slipped by 25.25% to $50.7 million in 2024, then sank by 63.8% to $18.4 million in 2025, then sank by 48.63% to $9.4 million in 2026.
- According to Business Quant data, Cash & Current Investments over the past three periods registered $9.4 million, $18.4 million, and $41.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.46 Bn | 193.86 Bn | 7.27 Bn | 5.60 Bn |
| 2 | Stryker | 127.41 Bn | 123.93 Bn | 4.50 Bn | 3.48 Bn |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn | 9.22 Bn |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn | 539.00 Mn |
| 5 | Edwards Lifesciences | 51.95 Bn | 47.69 Bn | 1.35 Bn | 4.25 Bn |
| 6 | Dexcom | 34.30 Bn | 32.35 Bn | 830.00 Mn | 1.95 Bn |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn | 2.11 Bn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.02 Bn | 4.55 Bn | 3.32 Bn |
| 9 | Steris | 23.04 Bn | 22.55 Bn | 684.20 Mn | 482.30 Mn |
| 10 | Rapid Micro Biosystems | 81.22 Mn | 61.46 Mn | 1.21 Mn | 19.77 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 19.77 Mn |
| Mar 31, 2026 | 9.43 Mn |
| Dec 31, 2025 | 18.37 Mn |
| Sep 30, 2025 | 41.25 Mn |
| Jun 30, 2025 | 31.26 Mn |
| Mar 31, 2025 | 22.86 Mn |
| Dec 31, 2024 | 50.73 Mn |
| Sep 30, 2024 | 60.83 Mn |
| Jun 30, 2024 | 32.37 Mn |
| Mar 31, 2024 | 57.20 Mn |
| Dec 31, 2023 | 67.87 Mn |
| Sep 30, 2023 | 65.90 Mn |
| Jun 30, 2023 | 77.59 Mn |
| Mar 31, 2023 | 99.69 Mn |
| Dec 31, 2022 | 81.78 Mn |
| Sep 30, 2022 | 114.89 Mn |
| Jun 30, 2022 | 144.09 Mn |
| Mar 31, 2022 | 162.23 Mn |
| Dec 31, 2021 | 15.41 Mn |
| Sep 30, 2021 | 219.59 Mn |